☰

Nitipol Ken Srimongkolpithak - Publications

Affiliations: 
National Center for Genetic Engineering and Biotechnology, Thailand 
Area:
medicinal chemistry
Tree Info Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Curry E, Green I, Chapman-Rothe N, Shamsaei E, Kandil S, Cherblanc FL, Payne L, Bell E, Ganesh T, Srimongkolpithak N, Caron J, Li F, Uren AG, Snyder JP, Vedadi M, et al. Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells. Clinical Epigenetics. 7: 84. PMID 26300989 DOI: 10.1016/S0959-8049(14)70680-X  0.53
2014 Srimongkolpithak N, Sundriyal S, Li F, Vedadi M, Fuchter MJ. Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4md00274a. Medchemcomm. 5: 1821-1828. PMID 25750706 DOI: 10.1039/C4Md00274A  0.545
2014 Sundriyal S, Malmquist NA, Caron J, Blundell S, Liu F, Chen X, Srimongkolpithak N, Jin J, Charman SA, Scherf A, Fuchter MJ. Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds. Chemmedchem. 9: 2360-73. PMID 25044750 DOI: 10.1002/Cmdc.201402098  0.563
2013 Cherblanc FL, Davidson RW, Di Fruscia P, Srimongkolpithak N, Fuchter MJ. Perspectives on natural product epigenetic modulators in chemical biology and medicine. Natural Product Reports. 30: 605-24. PMID 23396528 DOI: 10.1039/C3Np20097C  0.508
Show low-probability matches.